Group 1 - The controlling shareholder of Zhejiang Chengyi Pharmaceutical Co., Ltd. (hereinafter referred to as "Chengyi Pharmaceutical" or "the company") and its concerted actors plan to reduce their shareholdings [1] - As of the announcement date, the controlling shareholder Mr. Yan Yiyi holds 77,192,080 shares, accounting for 23.58% of the total share capital, while the concerted actor Wenzhou Dongtou Chengyi Microfinance Co., Ltd. holds 3,525,900 shares (1.08%), and Ms. Yan Xiaoling holds 349,722 shares (0.11%) [1] - The reduction plan involves a maximum of 3,875,622 shares, representing 1.18% of the total share capital, to be sold within three months starting from 15 trading days after the announcement [1][2] Group 2 - The reduction will be executed through centralized bidding or block trading, with the selling price determined by the market price at the time of the sale [1] - If the company undergoes any changes in total share capital due to stock dividends, capital reserve transfers, or other actions, the number and proportion of shares to be reduced will be adjusted accordingly [1] - The company will comply with relevant laws and regulations during the reduction process and fulfill its information disclosure obligations [3]

2025.09. 19 9月19日晚间，沪深两市多家上市公司发布公告，以下是第一财经对一些重要公告的汇总，供投资者 参考。 【品大事】 国晟科技：收到北京证监局行政监管措施决定书 国晟科技(603778)公告，公司于2025年9月19日收到北京证监局出具的《关于对国晟世安科技股份 有限公司、回全福、吴君、高飞、姚麒、张永胜采取责令改正措施的决定》。经查，公司存在园林业 务以前年度收入成本确认不准确，未在获知预计总成本变更的部分或全部事实时，及时进行会计估计 变更并调整相关收入、成本确认，导致2022年年报、2023年半年报和2023年年报相关信息披露不 准确等问题，北京证监局决定对公司及相关人员采取责令改正的监管措施，并记入证券期货市场诚信 档案。 思科瑞：股票将被实施其他风险警示 9月22日起停牌1天 思科瑞(688053)公告，公司收到四川证监局下发的《行政处罚事先告知书》，公司涉嫌信息披露违 法违规一案，已调查完毕，四川监管局依法拟对公司及相关人员作出行政处罚。经查明，思科瑞涉嫌 虚构销售业务、涉嫌提前确认收入、涉嫌不当确认收入，四川监管局拟决定对公司给予警告并处以 200万元罚款；对相关人员分别给予警 ...

Group 1 - Huadian Co., Ltd. plans to issue H-shares and list on the Hong Kong Stock Exchange [2] - Cisco Ray's 2022 annual report was found to have inflated revenue by 9.96 million and profit by 7.0054 million, leading to penalties and a change in stock name to ST Cisco Ray [3] - Tianpu Co., Ltd. experienced a 245.20% increase in stock price over 13 consecutive trading days, indicating a risk of rapid decline [4] - ST New Power is under investigation by the China Securities Regulatory Commission for suspected violations of information disclosure laws [6] - Baoli International intends to invest in semiconductor testing equipment company Hongtai Technology, acquiring 1%-3% equity [7] - Ankai Micro plans to invest 20 million yuan to acquire 4% equity in Shiqi Future, focusing on smart vision technology [8] Group 2 - SF Holding reported a revenue of 24.787 billion yuan in August, a year-on-year increase of 7.86% [9] - Various companies are involved in share transfers, including Guangli Micro and *ST Tianlong, with plans for significant asset restructuring [11] - Xinwangda's subsidiary aims to establish a storage industry fund with professional investment institutions [12] - Several companies are planning share repurchases, including Shunhao Co. and Lingyun Optics, with adjustments to repurchase plans [18]

北京商报讯(记者丁宁)9月19日晚间，诚意药业（603811）发布公告称，公司控股股东颜贻意之一致行 动人温州市洞头区诚意小额贷款股份有限公司(以下简称"诚意小贷")、颜晓玲拟以集中竞价交易方式或 大宗交易方式合计减持所持有的以集中竞价方式取得的公司无限售条件流通股不超过387.56万股，占公 司总股本的1.18%。 公告显示，诚意小贷持有公司股票352.59万股，占公司总股本比例为1.08%，颜晓玲持有公司股票34.97 万股，占公司当前股份总数的0.11%。 ...

Group 1 - Honghe Technology plans to increase capital by 300 million yuan to its wholly-owned subsidiary Huangshi Honghe through debt-to-equity conversion, raising its registered capital from 700 million yuan to 1 billion yuan [1] - Huaxia Happiness has completed debt restructuring amounting to approximately 192.67 billion yuan, with a total of 24 billion yuan in overdue debts as of August 31 [1] - Chengyi Pharmaceutical's controlling shareholder plans to reduce its stake by up to 1.18%, amounting to 387,560 shares [1][2] Group 2 - Yuanwang Valley received a warning letter from the Shenzhen Securities Regulatory Bureau for failing to halt trading when its controlling shareholder's stake changed to a multiple of 5% [2] - Gongjin Co. received government subsidies of 8.9 million yuan, accounting for 11.13% of its latest audited net profit [3] - Maiwei Biotech's application for the listing of 9MW0813 injection has been accepted by the National Medical Products Administration [4] Group 3 - Jianfeng Group plans to repurchase shares worth between 20 million and 40 million yuan at a maximum price of 12.42 yuan per share [6] - Ankai Micro plans to invest 20 million yuan to acquire a 4% stake in Shiqi Future [7] - Pinming Technology's stock will continue to be suspended as it is actively pursuing a significant matter that may lead to a change in control [8] Group 4 - China Communications has signed new contracts worth 256.34 billion yuan from January to August, with domestic contracts totaling 206.05 billion yuan [18] - Round Express reported a revenue of 5.39 billion yuan in August, a year-on-year increase of 9.82% [38] - China Pacific Insurance's original insurance premium income reached 217.05 billion yuan from January to August, up 13.2% year-on-year [39] Group 5 - *ST Chuangxing's chairman is under investigation, and the general manager will act as the chairman during this period [40] - Fengshan Group signed a technical development contract with Tsinghua University for a project related to sodium-ion battery electrolytes [40] - Yongxin Optical stated that its optical components related to lithography machines account for less than 1% of its revenue [41] Group 6 - Tianyuan Dike's subsidiary received a government subsidy of 3.77 million yuan, representing 16.27% of its latest audited net profit [42] - Huaxiang Co. plans to issue convertible bonds to raise no more than 1.308 billion yuan for various projects [43] - Wolong Electric Drive reported that its robot-related products accounted for only 2.71% of total revenue in the first half of the year [44]

每经AI快讯，诚意药业（SH 603811，收盘价：13.5元）9月19日晚间发布公告称，截至本公告披露日， 浙江诚意药业股份有限公司控股股东颜贻意先生持有公司股票约7719万股，占公司总股本比例为 23.58%，公司控股股东颜贻意先生之一致行动人温州市洞头区诚意小额贷款股份有限公司持有公司股 票约353万股，占公司总股本比例为1.08%，公司控股股东颜贻意先生之一致行动人颜晓玲女士持有公 司股票约35万股，占公司当前股份总数的0.11%。自本公告披露之日起15个交易日后的3个月内， 诚意小贷和颜晓玲拟以集中竞价交易方式或大宗交易方式合计减持所持有的以集中竞价方式取得的公司 无限售条件流通股不超过约388万股，占公司总股本的1.18%，减持价格将按照减持实施时的市场价格 确定。减持期间公司若实施送股、资本公积转增股本、配股等能够导致公司总股本发生变动的事项，则 相关计划减持股份数量及比例将相应进行调整。 截至发稿，诚意药业市值为44亿元。 每经头条（nbdtoutiao）——5万亿ETF的370名基金经理薪酬大揭秘！他们的日常工作，就是跟着指数 买股票吗？ （记者 王晓波） 2024年1至12月份，诚意药业的 ...

证券代码：603811 证券简称：诚意药业 公告编号：2025-056 浙江诚意药业股份有限公司 控股股东之一致行动人减持股份计划公告 本公司董事会、全体董事及相关股东保证本公告内容不存在任何虚假记载、 误导性陈述或者重大遗漏，并对其内容的真实性、准确性和完整性承担法律责任。 重要内容提示： | | 股东名称 | 持股数量（股） | 持股比例 | 一致行动关系形成原 | | --- | --- | --- | --- | --- | | | | | | 因 | | 第一 | 颜贻意 | 77,192,080 | 23.58% | 公司的控股股东、实 | | 组 | | | | 际控制人、董事长 | | | 温州市洞头区诚 | 3,525,900 | 1.08% | 颜贻意是诚意小贷法 | | | 意小额贷款股份 | | | 定代表人及董事长， | | | 有限公司 | | | 间接持有诚意小贷 | | | | | | 27.50%股权。 | | | 颜晓玲 | 349,722 | 0.11% | 颜晓玲是颜贻意的女 | | | | | | 儿及一致行动人。 | | | 合计 | 81,067,702 | 24 ...

格隆汇9月19日｜诚意药业(603811.SH)公告称，公司控股股东颜贻意的一致行动人温州市洞头区诚意小 额贷款股份有限公司和颜晓玲计划自公告披露之日起15个交易日后的3个月内，通过集中竞价交易或大 宗交易方式合计减持不超过3,875,622股，占公司总股本的1.18%。减持原因分别为根据国家金融监管总 局发布的《小额贷款公司监督管理暂行办法》规定需限期整改退出，以及个人资金需求。减持价格将按 减持实施时的市场价格确定。 ...

格隆汇9月19日丨诚意药业(603811.SH)公布，自本公告披露之日起15个交易日后的3个月内，诚意小贷 和颜晓玲拟以集中竞价交易方式或大宗交易方式合计减持所持有的以集中竞价方式取得的公司无限售条 件流通股不超过387.56万股，占公司总股本的1.18%，减持价格将按照减持实施时的市场价格确定。 ...

每经AI快讯，9月19日，诚意药业(603811.SH)公告称，公司控股股东颜贻意的一致行动人温州市洞头区 诚意小额贷款股份有限公司和颜晓玲计划自公告披露之日起15个交易日后的3个月内，通过集中竞价交 易或大宗交易方式合计减持不超过3,875,622股，占公司总股本的1.18%。减持原因分别为根据国家金融 监管总局发布的《小额贷款公司监督管理暂行办法》规定需限期整改退出，以及个人资金需求。减持价 格将按减持实施时的市场价格确定。 ...